Visby Medical announced Wednesday it has received FDA emergency use authorization for its single-use, rapid point-of-care COVID-19 polymerase chain reaction test.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,